Hepatitis C virus F protein: A double-edged sword in the potential contribution of chronic inflammation to carcinogenesis

Molecular Medicine Reports

Volumn 2, Issue 3, 2009, Pages 461-469

  Kong, Jing ^a,b   Deng, Xiaozhao ^a   Wang, Zhongchan ^a   Yang, Jingjing ^c   Zhang, Yun ^a   Yu, Juan ^c  

^a HUADONG RESEARCH INSTITUTE FOR MEDICINE AND BIOTECHNICS   (China)

^b HUAIYIN INSTITUTE OF TECHNOLOGY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Chronic inflammation; F protein; Hepatitis C virus; Hepatocellular carcinoma; IL 6; Viral load

Indexed keywords

INTERFERON; INTERLEUKIN 6; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; VIRUS F PROTEIN; VIRUS F PROTEIN ANTIBODY; VIRUS PROTEIN; VIRUS RNA;

ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN SPECIFICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; CANCER PATIENT; CELLULAR IMMUNITY; CHRONIC INFLAMMATION; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; PROTEIN FUNCTION; SERUM; T LYMPHOCYTE; VIRUS LOAD; VIRUS PATHOGENESIS;

HEPATITIS C VIRUS;

EID: 69249108831     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr-00000122     Document Type: Article

References (34)

1. Poynard T, Yuen MF, Ratziu V and Lai CL: Viral hepatitis C. Lancet 362: 2095-2100, 2003.
2. World Health Organization: Hepatitis C: Global prevalence. Weekly Epidemiol Rec 72: 341-344, 1997.
3. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW and Houghton M: Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244: 359-362, 1989. (Pubitemid 19117877)
4. Doi H, Apichartpiyakul C, Ohba KI, Mizokami M and Hotta H: Hepatitis C virus (HCV) subtype prevalence in Chiang Mai, Thailand, and identification of novel subtypes of HCV major type 6. J Clin Microbiol 34: 569-574, 1996. (Pubitemid 26065777)
5. Mellor J, Holmes EC, Jarvis LM, Yap PL and Simmonds P: Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. J Gen Virol 76: 2493-2507, 1995.
6. Bruno S, Silini E, Crosignani A, et al: Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study. Hepatology 25: 754-758, 1997. (Pubitemid 27106466)
7. Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P and Bréchot C: Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med 122: 161-168, 1995.
8. Marusawa H, Hijikata M, Chiba T and Shimotohno K: Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation. J Virol 73: 4713-4720, 1999. (Pubitemid 29246730)
9. Ray RB, Meyer K and Ray R: Suppression of apoptotic cell death by hepatitis C virus core protein. Virology 226: 176-182, 1996. (Pubitemid 27025796)
10. Chang J, Yang SH, Cho YG, Hwang SB, Hahn YS and Sung YC: Hepatitis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogene. J Virol 72: 3060-3065, 1998. (Pubitemid 28175546)
11. Ray RB, Lagging LM, Meyer K and Ray R: Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J Virol 70: 4438-4443, 1996. (Pubitemid 26187445)
12. Moriya K, Fujie H, Shintani Y, et al: The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 4: 1065-1067, 1998. (Pubitemid 28417341)
13. Varaklioti A, Vassilaki N, Georgopoulou U and Mavromara P: Alternate translation occurs within the core coding region of the hepatitis C viral genome. J Biol Chem 277: 17713-17721, 2002. (Pubitemid 34967576)
14. Walewski JL, Keller TR, Stump DD and Branch AD: Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame. RNA 7: 710-721, 2001.
15. Xu Z, Choi J, Yen TS, et al: Synthesis of a novel hepatitis C virus protein by ribosomal frameshift. EMBO J 20: 3840-3848, 2001. (Pubitemid 32691795)
16. Boulant S, Becchi M, Penin F and Lavergne JP: Unusual multiple recoding events leading to alternative forms of hepatitis C virus core protein from genotype 1b. J Biol Chem 278: 45785-45792, 2003. (Pubitemid 37432723)
17. Basu A, Steele R, Ray R and Ray RB: Functional properties of a 16 kDa protein translated from an alternative open reading frame of the core-encoding genomic region of hepatitis C virus. J Gen Virol 85: 2299-2306, 2004. (Pubitemid 39162603)
18. Ray RB, Steele R, Meyer K and Ray R: Hepatitis C virus core protein represses p21WAF1/Cip1/Sid1 promoter activity. Gene 208: 331-336, 1998. (Pubitemid 28120945)
19. Fiorucci M, Boulant S, Fournillier A, et al: Expression of the alternative reading frame protein of hepatitis C virus induces cytokines involved in hepatic injuries. J Gen Virol 88: 1149-1162, 2007. (Pubitemid 46523503)
20. Kong J, Diao Z, Deng X, Zhong H, Yao W and Hu X: Anti-tumor effects of immunotherapeutic peptide on the treatment of hepatocellular carcinoma with HBc carrier. Oncol Rep 18: 279-285, 2007.
21. Hu KQ, Yu CH and Vierling JM: One-step RNA polymerase chain reaction for detection of hepatitis C virus RNA. Hepatology 18: 270-274, 1993. (Pubitemid 23225095)
22. Roussel J, Pillez A, Montpellier C, Duverlie G, Cahour A, Dubuisson J and Wychowski C: Characterization of the expression of the hepatitis C virus F protein. J Gen Virol 84: 1751-1759, 2003. (Pubitemid 36805910)
23. Walewski JL, Gutierrez JA, Branch-Elliman W, et al: Mutation master: profiles of substitutions in hepatitis C virus RNA of the core, alternate reading frame, and NS2 coding regions. RNA 8: 557-571, 2002. (Pubitemid 34496576)
24. Balkwill F and Mantovani A: Inflammation and cancer: back to Virchow? Lancet 357: 539-545, 2001.
25. Karin M and Greten FR: NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5: 749-759, 2005. (Pubitemid 41400849)
26. Lohmann V, Körner F, Koch J, Herian U, Theilmann L and Bartenschlager R: Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285: 110-113, 1999. (Pubitemid 29307577)
27. Blight KJ, Kolykhalov AA and Rice CM: Efficient initiation of HCV RNA replication in cell culture. Science 290: 1972-1974, 2000.
28. Bost AG, Venable D, Liu L and Heinz BA: Cytoskeletal requirements for hepatitis C virus (HCV) RNA synthesis in the HCV replicon cell culture system. J Virol 77: 4401-4408, 2003. (Pubitemid 36350978)
29. Tsao ML, Chao CH and Yeh CT: Interaction of hepatitis C virus F protein with prefoldin 2 perturbs tubulin cytoskeleton organization. Biochem Biophys Res Commun 348: 271-277, 2006.
30. McMullan LK, Grakoui A, Evans MJ, et al: Evidence for a functional RNA element in the hepatitis C virus core gene. Proc Natl Acad Sci USA 104: 2879-2884, 2007. (Pubitemid 46327973)
31. Branch, AD, Walewski, JL, Gutierrez, JA, et al: HCV alternate reading frame proteins (ARFPs) may be virulence factors that help the virus survive adverse conditions. Hepatology 38: 468A-469A, 2003.
32. Abiru S, Migita K, Maeda Y, et al: Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis. Liver Int 26: 39-45, 2006.
33. Maione D, Di Carlo E, Li W, et al: Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver. EMBO J 17: 5588-5597, 1998. (Pubitemid 28445970)
34. Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM and Karin M: Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317: 121-124, 2007. (Pubitemid 47056470)